The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effects of vandetanib on body composition in patients with advanced medullary thyroid carcinomas: Results from a placebo-controlled study.
Marie-Helene Massicotte
No relevant relationships to disclose
Isabelle Borget
Other Remuneration - Genzyme
Sophie Leboulleux
No relevant relationships to disclose
Eric Baudin
No relevant relationships to disclose
Vickie E. Baracos
No relevant relationships to disclose
Merad Mansouriah
No relevant relationships to disclose
Martin Schlumberger
Consultant or Advisory Role - AstraZeneca
Honoraria - AstraZeneca
Sami Antoun
Consultant or Advisory Role - Bayer
Research Funding - Nutricia Medical Nutrition